|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan
2 Faculty of Bioscience, Mie University, Tsu-shi, Mie 514-8507, Japan
3 Yokohama Research Centre, Chisso Corporation, Kanazawa-ku, Yokohama 236-8605, Japan
4 The Photoprotein Laboratory, Falmouth, Massachusetts 02540, USA
(RECEIVED August 26, 2004; FINAL REVISION November 3, 2004; ACCEPTED November 3, 2004)
The photoprotein aequorin emits light by an intramolecular reaction in the presence of a trace amount of Ca2+. Semi-synthetic aequorins, produced by replacing the coelenterazine moiety in aequorin with the analogues of coelenterazine, show widely different sensitivities to Ca2+. To understand the structural basis of the Ca2+-sensitivity, we determined the crystal structures of four semi-synthetic aequorins (cp-, i-, br- and n-aequorins) at resolutions of 1.61.8 Å. In general, the protein structures of these semi-synthetic aequorins are almost identical to native aequorin. Of the four EF-hand domains in the molecule, EF-hand II does not bind Ca2+, and the loop of EF-hand IV is clearly deformed. It is most likely that the binding of Ca2+ with EF-hands I and III triggers luminescence. Although little difference was found in the overall structures of aequorins investigated, some significant differences were found in the interactions between the substituents of coelenterazine moiety and the amino acid residues in the binding pocket. The coelenterazine moieties in i-, br-, and n-aequorins have bulky 2-substitutions, which can interfere with the conformational changes of protein structure that follow the binding of Ca2+ to aequorin. In cp-aequorin, the cyclopentylmethyl group that substitutes for the original 8-benzyl group does not interact hydrophobically with the protein part, giving the coelenterazine moiety more conformational freedom to promote the light-emitting reaction. The differences of various semi-synthetic aequorins in Ca2+-sensitivity and reaction rate are explained by the capability of the involved groups and structures to undergo conformational changes in response to the Ca2+-binding.
Keywords: active sites; conformational changes; radiation damage; crystallography; photoprotein; EF-hand; Ca2+-binding protein; bioluminescence
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.041067805.
Reprint requests to: Atsushi Nakagawa, Institute for Protein Research, Osaka University, 32 Yamadaoka, Suita, Osaka 565-0871, Japan; e-mail: atsushi{at}protein.osaka-u.ac.jp; fax: +81-6-6879-4313.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Inouye Cloning, Expression, Purification and Characterization of an Isotype of Clytin, a Calcium-Binding Photoprotein from the Luminous Hydromedusa Clytia gregarium J. Biochem., May 1, 2008; 143(5): 711 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rowe, A. Rothert, C. Logue, C.M. Ensor, S.K. Deo, and S. Daunert Spectral tuning of photoproteins by partnering site-directed mutagenesis strategies with the incorporation of chromophore analogs Protein Eng. Des. Sel., February 1, 2008; 21(2): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tricoire, K. Tsuzuki, O. Courjean, N. Gibelin, G. Bourout, J. Rossier, and B. Lambolez Calcium dependence of aequorin bioluminescence dissected by random mutagenesis PNAS, June 20, 2006; 103(25): 9500 - 9505. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ohashi, S. Inouye, T. Yamazaki, and H. Hirota NMR Analysis of the Mg2+-Binding Properties of Aequorin, a Ca2+-Binding Photoprotein J. Biochem., November 1, 2005; 138(5): 613 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuzuki, L. Tricoire, O. Courjean, N. Gibelin, J. Rossier, and B. Lambolez Thermostable Mutants of the Photoprotein Aequorin Obtained by in Vitro Evolution J. Biol. Chem., October 7, 2005; 280(40): 34324 - 34331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |